Free tool
FAERS Monitor: Lansoprazole
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208025 or its brand name (Lansoprazole, Lansoprazole). Reports on generic versions are filed under their own applications.
Reports
107,664
Serious
99,937
93% of reports
Hospitalization
50,940
Death reported
13,581
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea6,722
- dyspnoea6,053
- nausea5,778
- off label use5,446
- fatigue5,367
- vomiting5,281
- acute kidney injury5,012
- malaise4,796
- headache4,788
- chronic kidney disease4,679
- pyrexia4,606
- dizziness4,143
- rash4,015
- arthralgia3,930
- drug ineffective3,851
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,299 |
| 2005 | 1,407 |
| 2006 | 1,111 |
| 2007 | 1,295 |
| 2008 | 1,663 |
| 2009 | 1,688 |
| 2010 | 1,874 |
| 2011 | 2,666 |
| 2012 | 3,288 |
| 2013 | 2,962 |
| 2014 | 3,515 |
| 2015 | 4,950 |
| 2016 | 5,797 |
| 2017 | 5,516 |
| 2018 | 8,294 |
| 2019 | 10,604 |
| 2020 | 7,738 |
| 2021 | 6,769 |
| 2022 | 6,859 |
| 2023 | 7,552 |
| 2024 | 8,133 |
| 2025 | 7,421 |
| 2026 | 5,262 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,946,495 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 4,679 | 12.8 | 12.4 | 47,725 |
| acute kidney injurySignal | 5,012 | 6.6 | 6.4 | 23,107 |
| pyrexiaSignal | 4,606 | 2.6 | 2.5 | 4,635 |
| vomitingSignal | 5,281 | 2.2 | 2.2 | 3,528 |
| malaiseSignal | 4,796 | 2.1 | 2.1 | 2,974 |
| dyspnoeaSignal | 6,053 | 2.1 | 2.0 | 3,548 |
| diarrhoeaSignal | 6,722 | 2.0 | 2.0 | 3,665 |
| arthralgia | 3,930 | 1.9 | 1.8 | 1,563 |
| rash | 4,015 | 1.8 | 1.8 | 1,463 |
| dizziness | 4,143 | 1.6 | 1.6 | 1,019 |
| headache | 4,788 | 1.5 | 1.5 | 804 |
| nausea | 5,778 | 1.4 | 1.4 | 768 |
| fatigue | 5,367 | 1.3 | 1.3 | 500 |
| off label use | 5,446 | 1.2 | 1.2 | 217 |
| drug ineffective | 3,851 | 0.6 | 0.6 | 1,332 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.